Dr. Dan-Arin Silasi, MD
Claim this profileDavid C. Pratt Center
Studies Cervical Cancer
Studies Ovarian Cancer
2 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Dan-Arin Silasi, MD is currently running
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting2 awards Phase 37 criteria
Robotic vs Open Hysterectomy
for Cervical Cancer
This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.
Recruiting1 award N/A8 criteria
More about Dan-Arin Silasi, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Dan-Arin Silasi, MD has experience with
- Da Vinci
- Open Surgery
- Bevacizumab
- Carboplatin
- Gemcitabine
- Olvimulogene Nanivacirepvec
Breakdown of trials Dan-Arin Silasi, MD has run
Cervical Cancer
Ovarian Cancer
Mixed Mullerian Tumor
Peritoneal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dan-Arin Silasi, MD specialize in?
Dan-Arin Silasi, MD focuses on Cervical Cancer and Ovarian Cancer. In particular, much of their work with Cervical Cancer has involved treating patients, or patients who are undergoing treatment.
Is Dan-Arin Silasi, MD currently recruiting for clinical trials?
Yes, Dan-Arin Silasi, MD is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Dan-Arin Silasi, MD has studied deeply?
Yes, Dan-Arin Silasi, MD has studied treatments such as da Vinci, Open Surgery, Bevacizumab.
What is the best way to schedule an appointment with Dan-Arin Silasi, MD?
Apply for one of the trials that Dan-Arin Silasi, MD is conducting.
What is the office address of Dan-Arin Silasi, MD?
The office of Dan-Arin Silasi, MD is located at: David C. Pratt Center, Saint Louis, Missouri 63141 United States. This is the address for their practice at the David C. Pratt Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.